Momentum Is Back At Cipla In Q2

However, The Indian Firm Has Seen Albuterol Delayed In US

Arrows_Coloured
Cipla Reports Strong Recovery In Q2 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business